CoChairs:

1

• Co-Chairs
• Constance Hanna, MD, Medical Director,
  Honeywell
• Roslyn Stone, MPH, C.O.O., Corporate Wellness,
  Inc.
• Membership
• Michael Mercado - President, national
  Association of Occupational Health
• Providers, Director, Northwest Community
  Occupational Health
• Pamela Dawkins, representing the American
  Association of Occupational Health
• Nurses, Emory University Occupational Health
  Center
• Robert Goldsmith, MD, Associate Medical
  Director, General Electric
• Beverly Doren, RN, COHN, Director, Occupational
  Health, General Electric
• Suzanne Mercure, Washington Business Group on
  Health
• Julie Gonen, Washington Business Group on
  Health
• David Wood, MD, President and Medical Director,
  Prevention MD

2
The Issues Defined by Workplace Flu Prevention
Working Group

• Late Delivery - vaccine arriving as late as
  December.
• Late vaccination scheduling - Mandated to delay
  start of vaccinations until
• November 1.
• High price of vaccine and seasonal price
  gouging.
• Price differential between vials and single
  dose prefilled syringes that
• drastically reduce vaccine waste in the
  workplace setting.
• Lack of safety devices on prefilled syringes.
• Returns policy.

3
Identified Solutions

• Creating and communicating realistic
  expectations for employers and
• employees regarding vaccination dates.
• Clarifying the intent of the ACIP - If there is
  a vaccine available, why
• cant it be given prior to November 1st?
• Dont schedule clinics / programs until vaccine
  for that clinic / program
• has arrived.

4
?s Posed to Three Manufacturers

• Why are flu vaccine costs what they are? What
  factors have contributed
• to the nearly doubling of price over the
  last decade?
• Why is the vaccine delivered as late as it is
  now? Are there built in delays?
• What would a dramatic reduction in workplace
  flu vaccine demand do to the
• economics of flu vaccine manufacture and
  delivery?
• Are you aware of or have an understanding of
  diminished / reduced workplace
• flu shot demand as the holidays approach?
• Why was the returns policy changed several
  years ago and what alternatives
• to the current Zero returns policy would
  you consider?
• Would you be willing to participate in a
  vaccine reallocation process - either
• through supporting a hotline or some other
  mechanism?

5
Issues That Remain Unresolved

• Late delivery
• Late vaccination scheduling - how can we give
  25 million doses in 3 weeks?
• High price of vaccine
• Price differential between vials and single
  dose prefilled syringes that
• drastically reduce vaccine waste in the
  workplace setting.
• Lack of safety devices on prefilled syringes
• Zero returns policy

?
?
?
?
6

• CONCLUSIONS/SOURCE OF SERIOUS CONCERN
• PRICE
• Increasing Price is decreasing the workplace
  demand.
• What will be the effect of a major
  decrease in the workplace
• demand and delivery of flu vaccine on the
  market?
• SHORTENED DELIVERY CHAIN
• FLU VACCINATION DELIVERY TIMELINE
• Is it realistic to expect to deliver 30 million
  doses of vaccine
• between Nov 1st and Thanksgiving?